THOMPSON SIEGEL & WALMSLEY LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 113 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$5,456,000
+7.5%
103,272
+24.7%
0.11%
+3.9%
Q2 2020$5,074,000
+7.1%
82,804
-1.1%
0.10%
-9.7%
Q1 2020$4,738,000
+1.2%
83,752
+1.9%
0.11%
+56.9%
Q4 2019$4,682,000
+400.7%
82,220
+370.9%
0.07%
+380.0%
Q3 2019$935,00017,4620.02%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders